AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Effect of a Pharmacist-led Multifaceted Intervention on Treatment Outcomes in Hypertensive Patients

RecruitingNAAges 18 Years - 80 YearsAllXijing Hospital
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

The objective of this cluster randomized controlled trial is to evaluate the effectiveness of a pharmacist-led multifaceted intensive blood pressure intervention on poorly controlled hypertensive patients in phase 1 (1 month, 3 months, 6 months, 12 months) and phase 2 (24 months) post randomization.

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria (subjects must meet all of the following criteria to be included): * 1\) age 18-80 years; * 2\) patients with hypertension (diagnostic criteria: defined as systolic blood pressure โ‰ฅ 140 mmHg or diastolic blood pressure โ‰ฅ 90 mmHg according to the "Guidelines for the prevention and treatment of hypertension in China in 2023", based on the blood pressure measurement of three times on different days), who are currently taking anti-hypertensive medication and are judged by the research physician to have poor blood pressure control; * 3\) able to use smartphones and WeChat proficiently, and can communicate and upload pictures proficiently; * 4\) able to take care of yourself and communicate normally, and willing to cooperate with the research physician to complete the study and follow-up; * 5\) permanent residents of the city where the center is located; * 6\) voluntarily participate and sign the informed consent form Exclusion Criteria(subjects will be excluded if they meet any of the following criteria): * 1\) patients with advanced disease (such as patients undergoing dialysis or liver failure), or with a life expectancy of less than 2 years as determined by the research physician; * 2\) combined with psychiatric disease, cognitive impairment, communication disorder, or inability to cooperate with the researchers; * 3\) combined with cerebrovascular disease, stroke, severe liver and kidney dysfunction, severe heart failure, cancer and history of organ transplantation, etc.; * 4\) patients who are pregnant, breastfeeding, or planning to conceive in the next 2 years.
๐Ÿ’Š

What it tests

  • pharmacist-led multifaceted intervention
  • conventional health education
๐Ÿ“

Where

1 site
Xijing hospital
Xi'an, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy